Clincosm LogoSign in Get a demo

Neoplasms by Histologic Type

Showing 26 - 43 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma, Carcinoma, Squamous Cell Trial in Aarhus, Copenhagen, Odense (radiation,

Recruiting
  • Oropharynx Cancer
  • +18 more
  • Intensity-Modulated Radiation Therapy (IMRT)
  • +3 more
  • Aarhus, Denmark
  • +2 more
Sep 28, 2021

Pralsetinib to Best Available Therapy in RET-Fusion Positive

Enrolling by invitation
  • RET-fusion Non Small Cell Lung Cancer
  • +16 more
    • New York, New York
    • +2 more
    Aug 9, 2021

    Spanish Series of Patients Treated With Radionuclide Lutetium177

    Recruiting
    • Neuroendocrine Tumors
    • +17 more
    • Lutetium [177Lu] oxodotreotide/dotatate
    • Santiago De Compostela, A Coruña, Spain
    • +18 more
    Jul 1, 2021

    Uterine Cervical Tumors, Uterine Cervical Cancer, Tumors, Squamous Cell Trial in Seattle (BD SurePath Plus Pap test, BD SurePath

    Terminated
    Has Results
    • Uterine Cervical Neoplasms
    • +6 more
    • BD SurePath Plus Pap test
    • +3 more
    • Seattle, Washington
      Seattle Women's: Health, Research, Gynecology
    Apr 12, 2021

    Physiological Effects of Drugs, Tumors by Histologic Type, Lymphoma Trial in Shanghai (SHR-1603)

    Suspended
    • Physiological Effects of Drugs
    • +5 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Mar 18, 2021

    Ovarian Tumors, Fallopian Tube Tumors, Tumors by Site Trial (Drug: Anlotinib, Drug: Carboplatin/Paclitaxel)

    Not yet recruiting
    • Ovarian Neoplasms
    • +14 more
    • Drug: Anlotinib
    • Drug: Carboplatin/Paclitaxel
    • (no location specified)
    Mar 17, 2021

    Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)

    Unknown status
    • Ovarian Neoplasms
    • +23 more
    • Nanjing, Jiangsu, China
      JiangSu Cancer Hospital
    Nov 8, 2020

    Ovarian Cancer, Ovarian and Fallopian Tube Cysts and Tumors, Tumors by Site Trial in Nanjing (Anlotinib, Olaparib)

    Recruiting
    • Ovarian Cancer
    • +18 more
    • Nanjing, Jangsu, China
      JiangSu Cancer Hospital
    Oct 29, 2020

    Tumors by Histologic Type Trial in Italy, United States (PF-03084014)

    Completed
    Has Results
    • Neoplasms by Histologic Type
    • Aurora, Colorado
    • +9 more
    Oct 21, 2019

    Low Rectal Cancer Study (MERCURY II)

    Unknown status
    • Adenocarcinoma
    • +15 more
      • Berlin, Germany
      • +16 more
      Sep 17, 2018

      Adenocarcinoma of the Rectum, Adenocarcinoma, Adenocarcinoma, Mucinous Trial in Worldwide (Patients who have surgery at 12 weeks

      Unknown status
      • Adenocarcinoma of the Rectum
      • +16 more
      • Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
      • Sao Paulo, Brazil
      • +22 more
      Sep 14, 2018

      Molecular, Pathologic and MRI Investigation of Prognostic and

      Unknown status
      • Adenocarcinoma
      • +15 more
        • Peterborough, Cambridgeshire, United Kingdom
        • +18 more
        Sep 13, 2018

        Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of varlilumab and sunitinib)

        Terminated
        • Carcinoma, Renal Cell
        • +8 more
        • Combination of varlilumab and sunitinib
        • Birmingham, Alabama
        • +8 more
        Jul 24, 2018

        Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of Varlilumab and Atezolizumab)

        Terminated
        • Carcinoma, Renal Cell
        • +13 more
        • Combination of Varlilumab and Atezolizumab
        • San Francisco, California
        • +3 more
        Apr 26, 2018

        Soft Tissue Sarcoma, Sarcoma, Tumors, Connective and Soft Tissue Trial (Doxorubicin, Trabectedin, Dexamethasone)

        Completed
        • Soft Tissue Sarcoma
        • +4 more
        • (no location specified)
        Jan 9, 2013

        Combined O-(2-[18F]Fluoroethyl)-L-tyrosine Positron Emission

        Unknown status
        • Glioblastoma
        • +8 more
          • Munich, Bavaria, Germany
            University of Munich, Dep. of Radiation Oncology
          Dec 17, 2012

          Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

          Terminated
          • Hepatocellular Carcinoma Non-resectable
          • +12 more
          • Beverly Hills, California
          • +162 more
          Sep 7, 2012

          PHENYTOIN/SORAFENIB [VA Drug Interaction], Liver Tumors, Carcinoma, Hepatocellular Trial in Jinan (Transarterial

          Unknown status
          • PHENYTOIN/SORAFENIB [VA Drug Interaction]
          • +11 more
          • Transarterial Chemoembolization (TACE)
          • Sorafenib in combination with TACE
          • Jinan, Shandong, China
            Shandong Cancer Hospital and Institute
          Apr 24, 2012